Skip to content

Evaluating the effect of Cinnamon on HbA1C in diabetic patients

Evaluating the effect of Cinnamon_Plus tablets on HbA1C in diabetic patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015010713612N4
Enrollment
70
Registered
2015-01-25
Start date
2015-02-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: In the first group Cinnamon Plus capsule will be used once daily for three months. Intervention 2: In the second group Placebo in form of a capsule will be used once daily for three mo
Treatment - Drugs
In the first group Cinnamon Plus capsule will be used once daily for three months.
In the second group Placebo in form of a capsule will be used once daily for three months.

Sponsors

Bone Research Center, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: type 2 diabetes mellitus; Patients aged from 18 to 65 years old; HbA1c less than 8, blood pressure less than 140/90. Exclusion criteria: diabetes type 1; Patients younger than 18 or older than 65 years; Having kidney, thyroid or liver disease simultaneously; HbA1c greater than 8; blood pressure over 140/90; Changing the dose or type of medication over the last six months; Pregnancy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hemoglobin A1c. Timepoint: At baseline and three months after satrting treatment. Method of measurement: Chromatography.;Body Mass Index. Timepoint: At baseline and three months after starting treatment. Method of measurement: weight(kg)÷height(m)^2.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Farzad Najafipour

Tabriz University of Medical Sciences

najafipourf@tbzmed.ac.ir+98 41 3337 4531

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026